A N Pharmaceuticals Private Limited, a active private limited company, was established on 22 November 2000 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233DL2000PTC108617. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.85 M.
It upholds a compliant status. Its leadership includes Anil Arora (Managing Director), Rishabh Arora (Director). Past directors included Ajay Jha, Anupama Bakshi, Ria Arora. It holds ₹18.62 Cr open charges and ₹5.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-1/4, Okhla Industrial Area, Phase-I, New Delhi, Delhi, 110020.
U24233DL2000PTC108617
108617
22 November 2000
₹1.00 Cr
₹9.85 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into A N Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Arora | Managing Director | 22 Nov 2000 | Current |
| Rishabh Arora | Director | 03 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Feb 2019 | Past |
| Pramod Abcsdd | Director | 01 Dec 2015 | Past |
| Pramod Abcsdd | Director | 11 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 11 Jan 2010 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
A N Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.79% increase. The company also saw a substantial improvement in profitability, with a 20.11% increase in profit. The company's net worth Soared by an impressive increase of 11.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, A N Pharmaceuticals had a promoter holding of 92.26% and a public holding of 7.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹186,161,000.00
₹51,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Dec 2024 | Hdfc Bank Limited | ₹8.45 Cr | Open |
| 03 May 2021 | Hdfc Bank Limited | ₹6.66 M | Open |
| 04 Jan 2021 | Hdfc Bank Limited | ₹9.50 Cr | Open |
| 09 Feb 2011 | Ing Vysya Bank Limited | ₹3.00 Cr | Satisfied |
| 26 Apr 2006 | Canara Bank | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with A N Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of A N Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A N Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 9.50 Cr registered on 04 Jan 2021 with Charge ID 100428576 was modified on 17 May 2025. was completed.
The activity A charge with Hdfc Bank Limited of Rs. 8.45 Cr registered on 25 Dec 2024 with Charge ID 101037768 was modified on 10 Mar 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 8.45 Cr with Charge ID 101037768 was registered on 25 Dec 2024. was recorded as a recent event.
Progress on A N Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A N Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Rishabh Arora was appointed as a Director was appointed as a Director on 03 Jan 2023 & has been associated with this company since 2 years 11 months . was documented.
The CIN of A N Pharmaceuticals Private Limited is U24233DL2000PTC108617.
A N Pharmaceuticals Private Limited is headquartered at F-1/4, Okhla Industrial Area, Phase-I, New Delhi, Delhi, 110020.
A N Pharmaceuticals Private Limited was incorporated on 22 November 2000.
The current directors of A N Pharmaceuticals Private Limited are
The primary industry of A N Pharmaceuticals Private Limited is Trade.
A N Pharmaceuticals Private Limited is unlisted.
The authorized capital of A N Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.85 M.
The compliance status of A N Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX